BRIEF-Ligand enters into worldwide omniab platform license agreement with Xcella Biosciences By: Reuters: Company News May 30, 2017 at 09:18 AM EDT * Ligand enters into worldwide omniab® platform license agreement with xcella biosciences Read More >> Related Stocks: Ligand Pharm